Sunflower Pharmaceutical Group Co.,Ltd

SZSE:002737.SZ

24 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Revenue 663.495440.35439.304995.3311,502.0621,444.4911,201.2731,268.4011,765.5221,865.025980.3181,050.6971,198.4721,445.65913.509885.0191,216.7221,255.549606.232690.079910.0281,220.298764.1161,174.251,212.751,336.989798.7091,245.1691,090.8891,234.411664.0081,121.311835.391,234.423593.964771.617763.577916.073605.772808.625704.302862.654604.673648.799602.634711.192483.695
Cost of Revenue 416.109430.011297.531477.067656.365738.778528.238525.788714.027833.266401.859433.502487.892536.052398.522375.116507.395483.08268.805301.745395.625463.387325.717515.74506.866496.348359.43536.586438.479481.158261.144478.467336.384459.646273.185361.484306.921403.1296.61357.43291.227327.303246.931251.005208.156258.734182.477
Gross Profit 247.38610.339141.773518.264845.697705.714673.035742.6131,051.4951,031.759578.459617.194710.58909.598514.987509.902709.327772.469337.427388.335514.403756.911438.398658.51705.883840.641439.279708.583652.41753.253402.863642.843499.006774.777320.78410.133456.656512.972309.161451.194413.075535.35357.742397.794394.478452.459301.218
Gross Profit Ratio 0.3730.0230.3230.5210.5630.4890.560.5850.5960.5530.590.5870.5930.6290.5640.5760.5830.6150.5570.5630.5650.620.5740.5610.5820.6290.550.5690.5980.610.6070.5730.5970.6280.540.5320.5980.560.510.5580.5870.6210.5920.6130.6550.6360.623
Reseach & Development Expenses 20.19147.0327.99426.11222.99431.25243.76130.17121.1688.41142.81437.63114.33944.33244.01837.13413.79252.50321.734.12214.48728.14929.0238.57327.47834.6230.83130.329.789143.32324.85847.395062.053032.448047.982020.128039.677018.778031.3290
General & Administrative Expenses 84.458-184.258237.711-55.931118.843-247.213303.667-57.415117.565149.858260.804-27.92985.904-166.19229.789-29.83283.482-124.39869.005-39.11968.237-147.70182.329-47.51793.762-159.88387.527-77.982125.956-208.511116.267-52.49699.55-134.53590.248-43.95676.943-94.9149.796-33.77463.891-111.12258.641-32.557.692169.3340
Selling & Marketing Expenses 82.216-346.29280.1122.621395.103357.56289.018321.822398.128442.556293.977210.231321.201329.406271.879286.22287.994318.422149.945183.109221.473339.605226.671352.431358.039470.8241.559388.959345.777410.493211.08387.412268.063418.454247.632260.7244.42283.917247.614269.489224.714311.894251.118203.375227814.6720
SG&A 166.674-685.19317.811218.338516.937452.468592.686264.407515.693603.794554.781182.302407.106163.216501.668256.388371.476194.024218.949143.99289.709191.905309.001304.915451.801310.918329.086310.977471.732201.982327.348334.916367.613283.919337.88216.744321.363189.007297.41235.715288.605200.772309.759170.874284.6921,006.4970
Other Expenses -12.184696.91-308.1140.867-1.859-1.149.273-16.5262.02810.681-170.266157.023-0.014-82.1260.15451.46842.4821.582.71-3.961-0.1275.2781.70110.1470.437-3.6469.229-1.2440.318-9.8939.516-3.48413.51832.5354.07624.40719.20731.83214.67813.6421.81612.8152.2024.1494.43-373.825-254.729
Operating Expenses 174.6856.76537.691243.583541.79484.86461.319462.035538.89622.886427.329376.957421.43542.185402.071443.75395.242408.905239.093276.735305.804498.009329.817467.37487.105564.295372.77523.634489.206523.264332.671503.562381.777570.388344.051350.77333.089407.715302.297344.027297.719387.751316.667262.837293.938-373.825-254.729
Operating Income 72.706-46.426104.082274.68303.907220.853226.555302.213514.911408.873141.516248.036286.565423.362111.81474.545275.482343.05199.729119.657204.185243.103105.607192.839218.863274.03663.558189.262188.891231.57370.558141.568111.367190.438-27.37157.215122.832114.9454.574110.441110.554135.58530.821123.56793.43178.63446.489
Operating Income Ratio 0.11-0.1050.2370.2760.2020.1530.1890.2380.2920.2190.1440.2360.2390.2930.1220.0840.2260.2730.1650.1730.2240.1990.1380.1640.180.2050.080.1520.1730.1880.1060.1260.1330.154-0.0460.0740.1610.1250.0080.1370.1570.1570.0510.190.1550.1110.096
Total Other Income Expenses Net -2.518-63.8160.08328.26233.716-4.672-6.1-0.382-0.13-0.410.209-3.8880.204-84.7940.15451.46842.4821.582.71-3.961-0.1275.2781.70110.1470.437-3.6469.229-1.2440.318-9.7129.361-3.7970.13432.0663.62924.40119.12330.79714.33713.6421.81612.8152.2024.1074.4324.6252.832
Income Before Tax 70.188-110.706104.165302.942338.087318.973220.455301.059514.781408.462141.725244.148286.77338.569111.968126.013317.964344.631102.439115.696204.058248.381107.307202.986219.3270.3972.787188.018189.209222.14879.919137.771124.883222.503-23.74281.616141.955145.74218.911124.083112.37148.433.024127.67597.861103.25949.321
Income Before Tax Ratio 0.106-0.2510.2370.3040.2250.2210.1840.2370.2920.2190.1450.2320.2390.2340.1230.1420.2610.2740.1690.1680.2240.2040.140.1730.1810.2020.0910.1510.1730.180.120.1230.1490.18-0.040.1060.1860.1590.0310.1530.160.1720.0550.1970.1620.1450.102
Income Tax Expense 11.346-7.09714.93556.59867.31940.59212.30557.51879.41635.53830.56152.80652.46528.98113.45114.85174.88267.96215.17420.69543.05632.90918.65250.08941.2128.8118.84137.96536.99128.00611.81738.21616.82429.84314.453.77335.02631.7351.09520.96619.79434.4141.99520.45919.007673.052-246.306
Net Income 57.112-94.79100.503231.149255.183267.956213.026232.025406.135358.151107.853182.046219.172304.03993.39881.432225.869267.66779.71182.932154.144192.09967.822142.448163.053217.82662.658136.295146.499178.13154.29793.21898.351180.344-43.48369.7696.394107.02117.5797.87584.134114.95627.96391.22473.20184.14240.898
Net Income Ratio 0.086-0.2150.2290.2320.170.1860.1770.1830.230.1920.110.1730.1830.210.1020.0920.1860.2130.1310.120.1690.1570.0890.1210.1340.1630.0780.1090.1340.1440.0820.0830.1180.146-0.0730.090.1260.1170.0290.1210.1190.1330.0460.1410.1210.1180.085
EPS 0.1-0.170.170.40.440.460.360.40.70.590.190.320.380.540.160.140.390.460.140.140.270.330.120.240.280.370.110.470.250.30.190.160.170.31-0.0750.120.170.270.0450.170.290.520.140.210.170.190.093
EPS Diluted 0.1-0.170.170.40.440.460.360.390.70.590.190.320.380.540.160.140.390.460.140.140.270.330.120.240.280.370.110.470.250.30.190.160.170.31-0.0740.120.170.270.0450.170.290.520.140.210.170.190.093
EBITDA 70.3-17.967105.43348.213383.41357.459258.723357.294573.017411.137236.809287.686331.95341.12163.007166.481319.064384.168142.488153.833245.124291.534149.982240.2256.513273.679.352215.373190.669248.99583.143162.438130.589274.51-20.4105.529123.567190.188.818137.218115.356-709.757357.742141.945100.541-556.94301.218
EBITDA Ratio 0.106-0.0410.240.350.2550.2470.2150.2820.3250.220.2420.2740.2770.2360.1780.1880.2620.3060.2350.2230.2690.2390.1960.2050.2120.2050.0990.1730.1750.2020.1250.1450.1560.222-0.0340.1370.1620.2080.0150.170.164-0.8230.5920.2190.167-0.7830.623